The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia

NCT05322031 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Myelin Degeneration
Cognition Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico